Professors call for review of way cancer drugs in NHS are rationed

BMJ 2008; 337 doi: (Published 27 August 2008) Cite this as: BMJ 2008;337:a1450
  1. Zosia Kmietowicz
  1. 1London

    The National Institute for Health and Clinical Excellence (NICE) has defended the way it decides which drugs should be funded by the NHS in England, after a group of 26 eminent oncologists from England and Scotland criticised its methods. They called for “a radical change in how the NHS makes rationing decisions for cancer.”

    In a letter to the Sunday Times on 24 August (, “Cancer drugs due a review”) the oncologists, headed by Karol Sikora, professor of cancer medicine at Imperial College London, called on NICE to get its “sums right.”

    They were …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to to receive unlimited access to all content on for 14 days.
    Sign up for a free trial